Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

Thinkingman91 Jul. 13 at 5:06 PM

$CLPT no one selling or flipping

0 · Reply

Twister8 Jul. 13 at 2:58 PM

$CLPT but but but all those shots on goal... just like a spaghetti toss

0 · Reply

EddieHayes Jul. 12 at 1:40 PM

5 small-cap growth names under a $2B market cap worth adding to your watchlist: $JMIA: Scaling its digital logistics network across Africa. $CLPT: Providing advanced navigation software for neurosurgeons. $EOSE: Zinc energy storage built for nonstop data center compute. $OSS: Deploying ruggedized edge compute for harsh environments. $CLFD: Building critical fiber infrastructure for edge data centers. While the crowd over-trades crowded mega-caps, institutional money quietly accumulates these low-float, asymmetric setups before the narrative goes mainstream. Which of these 5 small-cap leaders has the highest multi-bagger breakout potential? Drop your pick below and turn on notifications to lock in the next volume breakout setup early.

0 · Reply

SwingTraderPro1 Jul. 12 at 12:52 AM

Hunting for the next small-cap winners? I'm keeping a close eye on companies under roughly $2B market cap that are exposed to long-term secular growth themes like AI infrastructure, robotics, energy storage, and defense tech. $JMIA - Expanding e-commerce and logistics across Africa $CLPT - AI-assisted navigation solutions for neurosurgery $EOSE - Long-duration energy storage and grid-scale batteries $OSS -Rugged edge computing for defense and AI applications $CLFD - Fiber connectivity supporting AI, broadband, and edge infrastructure Small caps can be volatile, but that's often where the biggest growth stories begin. Which one is on your watchlist? Turn post notifications on to get an early entry i do not need to charge you because i actually make money trading

0 · Reply

FibonacciTrader_ Jul. 11 at 6:35 PM

Small-cap opportunities often hide in the areas where major growth trends are just getting started. Here are 5 under-the-radar names I’m watching with exposure to emerging themes: $JMIA → Scaling logistics and e-commerce across Africa $CLPT → Surgical navigation technology for neurosurgery $EOSE → Energy storage solutions for growing power demand $OSS → Rugged edge computing for defense applications $CLFD → Fiber infrastructure supporting edge data centers Different sectors, but one common theme: companies positioned around future growth markets. Small caps bring higher risk, but they can also offer significant upside if execution and adoption accelerate. If you want to see the high-conviction stocks I’m watching, my full portfolio, and every trade I make… Head to my profile.

0 · Reply

MarketMaestro1 Jul. 11 at 4:40 PM

Small caps are where the biggest moves happen when fundamentals meet the right trends. Watching: $JMIA — Emerging market growth + turnaround potential $CLPT — Medical technology with strong platform value $EOSE — Energy storage play tied to future power demand $OSS — Edge AI + defense infrastructure $CLFD — Fiber backbone for next-gen connectivity The next big winners may come from companies solving real-world problems in AI, energy, healthcare, and infrastructure. BUT: All these names are highly volatile. That’s why the right entry matters more than ever — not just to maximize gains, but also to control risk. The detailed stock list and strategies have been shared with the community; please visit my profile to view them. Which small caps are you watching?

0 · Reply

SmartMoneyRadar Jul. 11 at 3:18 PM

5 SMALL-CAP NAMES UNDER $2B WORTH WATCHING 👀 Finding opportunities before they become crowded is where the biggest advantages often come from. These small-cap companies are working on interesting themes across logistics, healthcare, energy storage, and next-generation infrastructure. Watchlist: $JMIA Scaling logistics across Africa $CLPT Navigation software helping neurosurgeons $EOSE Zinc-based energy storage for growing power demand $OSS Rugged edge computing solutions $CLFD Fiber infrastructure supporting edge data centers Small caps come with higher risk, but early-stage companies can create unique opportunities when the market starts paying attention. Investing doesn’t have to be complicated. Just listen to the smart money. Follow for more.

0 · Reply

Thinkingman91 Jul. 9 at 6:43 PM

$CLPT toy with it all you want I know where it’s going

1 · Reply

Thinkingman91 Jul. 8 at 8:08 PM

$CLPT spaghetti tonight?

0 · Reply

Twister8 Jul. 7 at 10:41 PM

$CLPT looking for sub 15 soon.

1 · Reply

ClearPoint Neuro price target raised to $30 from $20 at B. Riley

QURE

2026-06-17T12:43:10.000Z - 27 days ago

ClearPoint Neuro up 32% after uniQure announces plan for AMT-130 BLA submission

QURE

2026-05-27T20:51:32.000Z - 6 weeks ago

ClearPoint Neuro enters development partnership with Sungkyunkwan University

May 27, 2026, 4:30 PM EDT - 6 weeks ago

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-05-13T21:56:29.000Z - 2 months ago

ClearPoint Neuro receives CE Marking for Velocity Alpha MR

2026-05-13T21:26:39.000Z - 2 months ago

ClearPoint Neuro reports Q1 EPS (32c) vs. (22c) last year

2026-05-13T21:24:39.000Z - 2 months ago

ClearPoint Neuro sees FY26 revenue $52M-$56M, consensus $53.03M

May 13, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Reports First Quarter 2026 Results

May 13, 2026, 4:00 PM EDT - 2 months ago

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

May 13, 2026, 7:00 AM EDT - 2 months ago

ClearPoint Neuro Slides: Investor presentation

2026-05-08T13:16:56.000Z - 2 months ago

ClearPoint Neuro resumed with a Buy at Stifel

Apr 29, 2026, 4:05 PM EDT - 2 months ago

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

Apr 23, 2026, 8:00 AM EDT - 2 months ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-04-22T21:06:43.000Z - 2 months ago

ClearPoint Neuro announces first clinical use of Velocity Alpha MR drill

Apr 22, 2026, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-04-20T20:16:48.000Z - 3 months ago

ClearPoint Neuro announces Canadian approval for Neuro Navigation System

Apr 20, 2026, 4:05 PM EDT - 3 months ago

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Apr 10, 2026, 8:00 AM EDT - 3 months ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-03-18T12:50:37.000Z - 4 months ago

ClearPoint Neuro price target raised to $20 from $18 at B. Riley

Mar 17, 2026, 4:30 PM EDT - 4 months ago

ClearPoint Neuro Earnings Call Transcript: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 4 months ago

ClearPoint Neuro Annual report: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 4 months ago

ClearPoint Neuro Earnings release: Q4 2025

Mar 17, 2026, 4:05 PM EDT - 4 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Mar 17, 2026, 7:00 AM EDT - 4 months ago

ClearPoint Neuro Slides: Corporate presentation

Mar 6, 2026, 8:00 AM EST - 4 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

2026-03-05T14:22:39.000Z - 4 months ago

ClearPoint Neuro price target lowered to $18 from $28 at B. Riley

QURE

Jan 22, 2026, 4:30 PM EST - 6 months ago

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

2026-01-14T21:11:05.000Z - 6 months ago

ClearPoint Neuro files to sell 1.31M shares of common stock for holders

Jan 14, 2026, 7:00 AM EST - 6 months ago

ClearPoint Neuro Registration statement: Registration Filing

2026-01-12T14:41:40.000Z - 6 months ago

ClearPoint Neuro sees Q4 revenue $10.4M, up 20% y/y

2026-01-12T14:41:28.000Z - 6 months ago

ClearPoint Neuro sees FY26 revenue $54M-$60M

Jan 12, 2026, 8:30 AM EST - 6 months ago

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Nov 20, 2025, 5:00 PM EST - 8 months ago

ClearPoint Neuro Completes Acquisition of IRRAS

2025-11-06T22:45:29.000Z - 8 months ago

ClearPoint Neuro acquires Irras Holdings, terms undisclosed

Nov 6, 2025, 4:55 PM EST - 8 months ago

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:50 PM EST - 8 months ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 6, 2025, 4:30 PM EST - 8 months ago

ClearPoint Neuro Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

ClearPoint Neuro Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

ClearPoint Neuro Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

ClearPoint Neuro Slides: Investor Presentation

Nov 5, 2025, 5:02 PM EST - 8 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Oct 7, 2025, 4:15 PM EDT - 9 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 10 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 1, 2025, 4:05 PM EDT - 10 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 4:05 PM EDT - 10 months ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 12, 2025, 4:30 PM EDT - 11 months ago

ClearPoint Neuro Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

ClearPoint Neuro Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

ClearPoint Neuro Earnings release: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 12, 2025, 7:00 AM EDT - 1 year ago

ClearPoint Neuro Slides: Investor Presentation

Aug 4, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

May 13, 2025, 4:40 PM EDT - 1 year ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings release: Q1 2025

May 12, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Apr 9, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Proxy statement: Proxy Filing

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q4 2024

Feb 26, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 1 year ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Slides: Q2 2024

Jul 17, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 20, 2024, 8:45 AM EDT - 2 years ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 2 years ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 2 years ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Quarterly report: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q1 2024

Apr 16, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Apr 5, 2024, 8:00 AM EDT - 2 years ago

ClearPoint Neuro Proxy statement: Proxy Filing

Mar 19, 2024, 8:07 AM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Annual report: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q4 2023

Mar 12, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Feb 29, 2024, 8:00 AM EST - 2 years ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

Feb 28, 2024, 4:45 PM EST - 2 years ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

Jan 25, 2024, 12:00 PM EST - 2 years ago

ClearPoint Neuro Transcript: Status Update

Jan 24, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

Jan 22, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Jan 8, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Thinkingman91 Jul. 13 at 5:06 PM

$CLPT no one selling or flipping

0 · Reply

Twister8 Jul. 13 at 2:58 PM

$CLPT but but but all those shots on goal... just like a spaghetti toss

0 · Reply

EddieHayes Jul. 12 at 1:40 PM

0 · Reply

SwingTraderPro1 Jul. 12 at 12:52 AM

0 · Reply

FibonacciTrader_ Jul. 11 at 6:35 PM

0 · Reply

MarketMaestro1 Jul. 11 at 4:40 PM

0 · Reply

SmartMoneyRadar Jul. 11 at 3:18 PM

0 · Reply

Thinkingman91 Jul. 9 at 6:43 PM

$CLPT toy with it all you want I know where it’s going

1 · Reply

Thinkingman91 Jul. 8 at 8:08 PM

$CLPT spaghetti tonight?

0 · Reply

Twister8 Jul. 7 at 10:41 PM

$CLPT looking for sub 15 soon.

1 · Reply

johnnygogogo Jul. 2 at 4:47 PM

$CLPT would like this company a lot more if Burnett didn’t sell shares and options so often. I don’t care if it’s on a 10b51 plan.

1 · Reply

Twister8 Jul. 2 at 2:56 PM

$CLPT perhaps a new can of spaghetti?

0 · Reply

Twister8 Jul. 1 at 3:57 PM

$CLPT what is sticking today?

1 · Reply

Thinkingman91 Jul. 1 at 2:10 PM

$CLPT flag break

3 · Reply

Twister8 Jun. 30 at 7:01 PM

$CLPT still a log jam for the iMRI suites? LOL

0 · Reply

Thinkingman91 Jun. 30 at 6:07 PM

$CLPT what did I tell you

1 · Reply

Thinkingman91 Jun. 30 at 4:26 PM

$CLPT down 8% in a day going to rebound

0 · Reply

Thinkingman91 Jun. 30 at 4:22 PM

$CLPT flag break up

0 · Reply

Thinkingman91 Jun. 30 at 2:58 PM

$CLPT a bum that’s silent for days only to post right before it goes to 20+ lol idiot

0 · Reply

Twister8 Jun. 30 at 1:54 PM

$CLPT just cant make this up, pump and dump the spaghetti toss

0 · Reply

Stockswingalert Jun. 29 at 6:32 PM

$CLPT if you late here to the 💎 party 🔐 sponsored by #lockedintrading @Stockswingalert LLC My good exclusive karma and way to pay it forward for my OG crowd on here cc @Stocktwits 🙏🎯👇💰 for ONLY free.99 🤝🤝🤝 Is to watch the gap fill here at $19.68 ☢️📈 In a world selling gold (gene therapy), sometimes the better bet is to buy the shovels… In this case that is this right here 👇👇👇 cc $QURE $CRSP $RHHBY #roche

0 · Reply

MAGA1717 Jun. 29 at 4:44 PM

$CLPT 🤡🤡🤡👇

2 · Reply

Market Cap	524.83M
Revenue (ttm)	36.97M
Net Income (ttm)	-25.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-69.08%
Debt to Equity Ratio	2.63

Volume	522,100
Avg Vol	771,698
Day's Range	N/A - N/A
Shares Out	29.99M
Stochastic %K	8%
Beta	1.23
Analysts	Strong Sell
Price Target	$28.33